» Articles » PMID: 11418607

Characterization of Human Mucin Gene MUC4 Promoter: Importance of Growth Factors and Proinflammatory Cytokines for Its Regulation in Pancreatic Cancer Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Jun 22
PMID 11418607
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The human mucin gene MUC4 encodes a large transmembrane mucin that is thought to play important roles in tumor cell biology and that is overexpressed in human pancreatic carcinomas. In this report, we describe the structure and functional activity of the 5'-flanking region, including 1.0 kilobase of the promoter. The long 5'-untranslated region (2.7 kilobases) is characterized by a high content of GC in its 3'-end. The first TATA box was located at -2672/-2668. Multiple transcription start sites and a high density of putative binding sites for Sp1 (GC and CACCC boxes), AP-1/-2/-4, cAMP-responsive element-binding protein, GATA, GR, and STAT transcription factors were found within the 5'-flanking region. Transcriptional activity of the promoter was assessed using pGL3-luciferase deletion mutants in two MUC4-expressing (CAPAN-1 and CAPAN-2) and one nonexpressing (PANC-1) pancreatic cancer cell line. Two highly active fragments (-219/-1 and -2781/-2572) that drive MUC4 transcription in CAPAN-1 and CAPAN-2 cells were identified. Gel retardation assays indicated that Sp1 and Sp3 bind to cognate cis-elements found in the 5'-flanking region and that Sp1 transactivates, whereas Sp3 inhibits the GC-rich region (-464/-1) in CAPAN-2 cells. Activation of protein kinase C with phorbol ester and treatment of cells with epidermal growth factor and transforming growth factor-alpha resulted in up-regulation of the promoter. Tumor necrosis factor-alpha and interferon (IFN)-gamma inflammatory cytokines had no or mild effect on MUC4 transcriptional activity when used alone. However, a very strong synergistic effect (10-12-fold activation) between IFN-gamma and tumor necrosis factor-alpha or IFN-gamma and transforming growth factor-alpha was obtained in CAPAN-2 cells. Altogether these results demonstrate that the 5'-flanking region of MUC4 contains epithelial cell-specific, positive, and negative regulatory cis-elements, that Sp1/Sp3 are important regulators of MUC4 basal expression, and that its regulation in pancreatic cancer cells involves complex interplay between several signaling pathways.

Citing Articles

Single-cell Profiling Uncovers a -Expressing Metaplastic Gastric Cell Type Sustained by -driven Inflammation.

OBrien V, Kang Y, Shenoy M, Finak G, Young W, Dubrulle J Cancer Res Commun. 2023; 3(9):1756-1769.

PMID: 37674528 PMC: 10478791. DOI: 10.1158/2767-9764.CRC-23-0142.


Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma.

Boukrout N, Souidi M, Lahdaoui F, Duchene B, Neve B, Coppin L Cancers (Basel). 2021; 13(24).

PMID: 34944818 PMC: 8699468. DOI: 10.3390/cancers13246197.


The role of membrane mucin MUC4 in breast cancer metastasis.

Dreyer C, VanderVorst K, Free S, Rowson-Hodel A, Carraway K Endocr Relat Cancer. 2021; 29(1):R17-R32.

PMID: 34726614 PMC: 8697635. DOI: 10.1530/ERC-21-0083.


Mucins as a New Frontier in Pulmonary Fibrosis.

Ballester B, Milara J, Cortijo J J Clin Med. 2019; 8(9).

PMID: 31514468 PMC: 6780288. DOI: 10.3390/jcm8091447.


MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.

Gautam S, Kumar S, Cannon A, Hall B, Bhatia R, Nasser M Expert Opin Ther Targets. 2017; 21(7):657-669.

PMID: 28460571 PMC: 5706649. DOI: 10.1080/14728222.2017.1323880.